Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission

British Journal of Haematology

Volumn 102, Issue 2, 1998, Pages 486-494

  Delforge, Michel ^a   Demuynck, Hilde ^a   Verhoef, Gregor ^a   Vandenberghe, Peter ^a   Zachee, Pierre ^a   Maertens, Johan ^a   Van Duppen, Viktor ^a   Boogaerts, Marc A ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chemotherapy; Clonality; HUMARA assay; Myelodysplastic syndrome

Indexed keywords

ANDROGEN; ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; ERYTHROPOIETIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MITOXANTRONE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CELL CLONE; CHILD; CLINICAL ARTICLE; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HIGH RISK PATIENT; HUMAN; HUMAN CELL; KARYOTYPE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REMISSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; B-LYMPHOCYTES; CHILD; CLONE CELLS; DOSAGE COMPENSATION, GENETIC; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; RECEPTORS, ANDROGEN; REMISSION INDUCTION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0031869587     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00797.x     Document Type: Article

References (43)

1. Abrahamson, G., Boultwood, J., Madden, J., Kelly, S., Oscier, D., Rack, K., Buckle, V. & Wainscoat, J. (1991) Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses. British Journal of Haematology, 79, 550-555.
2. Abruzzese, E., Buss, D., Rainer, R., Pettenati, M. & Rao, P. (1996a) Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukemia: a case report and cell lineage study. Annals of Hematology, 73, 35-38.
3. Abruzzese, E., Buss, D., Rainer, R., Rao, P. & Pettenati, M. (1996b) Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization. Leukemia Research, 20, 551-557.
4. Allen, R., Zoghbi, H., Moseley, A., Rosenblatt, H. & Belmont, J. (1992) Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. American Journal of Human Genetics, 51, 1229-1239.
5. Anan, K., Ito, M., Misawa, M., Ohe, Y., Kohsaki, M. & Hara, H. (1995) Clonal analysis of peripheral blood and haemopoietic colonies in patients with aplastic anaemia and refractory anaemia using the short tandem repeat on the human androgen-receptor (HUMARA) gene. British Journal of Haematology, 89, 838-844.
6. Anastasi, J., Feng, J., LeBeau, M., Larson, R., Rowley, J. & Vardiman, J. (1993) Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood, 81, 1580-1585.
7. Asano, H., Ohashi, H., Ichihara, M., Kinoshita, T., Murate, T., Kobayashi, M., Saito, H. & Hotta, T. (1994) Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. Blood, 84, 588-594.
8. Ascensao, J., Kay, N., Wright, J., Arthur, D., Finkel, B., Rydell, R. & Kaplan, M. (1986) Lymphoblastic transformation of myelodysplastic syndrome. American Journal of Hematology, 22, 431-434.
9. Asimakopoulos, F., Holloway, T., Nacheva, E., Scott, M. Fenaux, P. & Green, A. (1996) Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes. Blood, 87, 1561-1570.
10. Bennett, J., Catovsky, D., Daniel, M., Flandrin, G., Galton, D., Gralnick, H. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
11. Boogaerts, M., Verhoef, G. & Demuynck, H. (1996) Treatment and prognostic factors in myelodysplastic syndromes. Baillières Clinical Haematology, 9, 161-183.
12. Busque, L. & Gilliland, D. (1993) Clonal evolution in acute myeloid leukemia. Blood, 82, 337-342.
13. Busque, L., Mio, R., Mattioli, J., Brais, K., Blais, N., Lalonde, Y., Maragh, M. & Gilliland, D. (1996) Nonrandom X-inactivation patterns in normal females: Lyonization ratios vary with age. Blood, 88, 59-65.
14. Carella, A., Dejana, A., Lerma, E., Podesta, M., Benvenuto, E., Chimirri, F., Parodi, C., Sessarego, M., Prencipe, E. & Frassoni, F. (1996) In vivo mobilization of karyotypically normal peripheral blood progenitor cells in high-risk MDS, secondary or therapy-related acute myelogenous leukaemia. British Journal of Haematology, 95, 127-130.
15. Champion, K., Gilbert, J., Asimakopoulos, F., Hinshelwood, S. & Green, A. (1997) Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. British Journal of Haematology, 97, 920-926.
16. Copplestone, J.A., Mufti, G.J., Hamblin, T.J. & Oscier, D.G., (1986) Immunological abnormalities in myelodysplastic syndromes, II. Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy. British Journal of Haematology, 63, 149-159.
17. Culligan, D., Cachia, P., Whittaker, J., Jacobs, A. & Padua, R. (1992) Clonal lymphocytes are detectable in only some cases of MDS. British Journal of Haematology, 81, 346-352.
18. Delforge, M., Demuynck, H., Vandenberghe, P., Verhoef, G., Zachée, P., Van Duppen, V., Marijnen, P., Van den Berghe, H. & Boogaerts, M. (1995) Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk myelodysplastic syndromes. Blood, 86, 3660-3667.
19. Demuynck, H., Delforge, M., Verhoef, G., Zachée, P., Vandenberghe, P. & Boogaerts, M. (1996) Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor-risk myelodysplastic syndromes. British Journal of Haematology, 92, 351-359.
20. de Witte, T., Van Biezen, A., Hermans, J., Labopin, M., Runde, V., Or, R., Meloni, G., Mauri, S., Carella, A., Apperley, J., Gratwohl, A. & Laporte, J., for the chronic and acute leukemia working parties of the European Group for Blood and Marrow Transplantation (1997) Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Blood, 90, 3853-3857.
21. Fialkow, P., Janssen, J. & Bartram, C. (1991) Clonal remissions in acute nonlymphocytic leukemia: evidence for a multistep pathogenesis of the malignancy. Blood, 77, 1415-1417.
22. Fugazza, G., Bruzzone, R., Dejana, A., Gobbi, M., Ghio, R., Patrone, E. Rattenni, S. & Sessarego, M. (1995) Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization. Leukemia, 9, 109-114.
23. Gale, R., Wheadon, H., Goldstone, A., Burnett, A. & Linch, D. (1993) Frequency of clonal remission in acute myeloid leukaemia, Lancet, 341, 138-142.
24. Gale, R., Wheadon, H. & Linch, D. (1994) Tissue specificity of X-chromosome inactivation patterns. Blood, 83, 2899-2905.
25. Gale, R., Mein, C. & Linch, D. (1996) Quantification of X-chromosome inactivation patterns in haematological samples using the DNA PCR-based HUMARA assay. Leukemia, 10, 362-367.
26. Ganser, A., Janssen, J., Ottman, O., Seipelt, G., Eder, M., Becher, R., Lindermann, A., Herrmann, E., Schulz, G., Mertelsman, R., Hoelzer, D. & Bartram, C. (1991) In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders. Leukemia, 5, 487-492.
27. Gerritsen, W., Donohue, J., Bauman, J., Jhanwar, S., Kernan, N., Gastro-Malaspina, H., Reilly, R.O. & Bourhis, J. (1992) Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood, 80, 217-224.
28. Ito, T., Ohashi, H., Ichikawa, A., Saito, H. & Hotta, T. (1994) Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy. Leukemia, 8, 839-843.
29. Janssen, J., Buschle, M., Layton, M., Drexler, H., Lyons, J., Van den Berghe, H., Heimpel, H., Kubanek, B., Kleihauer, E., Mufti, G. & Bartram, C. (1989) Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood, 73, 248-254.
30. Kibbelaar, R., Van Kamp, H., Dreef, E., de Groot-Swings, G., Kluin-Nelemans, J., Beverstock, G., Fibbe, W. & Kluin, P. (1992) Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood, 79, 1823-1828.
31. Kroef, M., Fibbe, W., Mout, R., Jansen, R., Haak, H., Wessels, J., Van Kamp, H., Willemze, R. & Landegent, J. (1993) Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. Blood, 81, 1849-1854.
32. Lawrence, H., Broudy, V., Magenis, R., Olson, S., Tomar, D., Barton, S., Fitchen, J. & Bagby, G. (1987) Cytogenetic evidence for involvement of B lymphocytes in acquired idiopathic sideroblastic anemias. Blood, 70, 1003-1005.
33. Mitterbauer, G., Schwarzmeier, J., Mitterbaucr, M., Jaeger, U., Fritsch, G. & Schwarzinger, I. (1997) Myelodysplastic syndrome/acute myeloid leukemia supervening previously untreated chronic B-lymphocytic leukemia: demonstration of the concomitant presence of two different malignant clones by immunologic and molecular analysis. Annals of Hematology, 74, 193-197.
34. Osmond, D. (1993) The turnover of B-cell populations. Immunology Today, 14, 34-37.
35. Prchal, J., Throckmorton, D., Carroll, A., Fuson, E., Gams, R. & Prchal, J. (1978) A common progenitor for human myeloid and lymphoid cells. Nature, 274, 590-591.
36. Raskind, W., Tirumali, N., Jacobson, R., Singer, J. & Fialkow, P. (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood, 63, 1318-1323.
37. Tefferi, A., Thibodeau, S. & Solberg, L. (1990) Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood, 75, 1770-1773.
38. Tsukamoto, N., Morita, K., Maehara, T., Okamoto, K., Karasawa, M., Omine, M. & Naruse, T. (1993) Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. British Journal of Haematology, 83, 589-594.
39. Vadhan-Raj, S., Broxmeyer, H., Spitzer, G., LeMaistre, A., Hultman, S., Ventura, G., Tigaud, J., Cork, M. Trujillo, M., Gutterman, J. & Hittelman, W. (1989) Stimulation of nonclonal hematopoiesis and suppression of the neoplastic clone after treatment with recombinant human granulocyte-macrophage colony-stimulating factor in a patient with therapy-related myelodysplastic syndrome. Blood, 74, 1491-1498.
40. Van Kamp, H., Fibbe, W., Jansen, R., Van der Keur, M., Graaff, E.D., Willemze, R. & Landegent, J. (1992) Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells, in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene. Blood, 80, 1774-1780.
41. Van Lom, K., Hagemeijer, A., Smit, E., Hählen, K., Groeneveld, K. & Löwenberg, B. (1995) Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and lymphoid lineage. Leukemia, 9, 1818-1821.
42. Weimar, I., Bourhis, J., de Gast, G. & Gerritsen, W. (1994) Clonality in myelodysplastic syndromes. Leukemia and Lymphoma, 13, 215-221.
43. White, N., Nacheva, E., Asimakopoulos, F., Bloxham, D., Paul, B. & Green, A. (1994) Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood, 83, 2809-2816.